Company intelligence / Profile preview

Stemlogix

Weston, Florida, United States

Ownership: Private
Development stage: Other

Overview

Stemlogix provided veterinarians with the ability to produce stem cell therapies in-clinic or stall-side using both adipose-derived and bone marrow-derived stem cells in same-day procedures[1]. The company also offered culture-expanded stem cells and banking services for future use[1].

Therapeutic areas: Other
Modalities: Stem cell therapy
Industry: Veterinary

Beyond the preview

Go deeper on Stemlogix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stemlogix.

Explore the full profile